NuVasive Financials

NuVasive Stock Summary

NuVasive competes with Glaukos Corp, CONMED, LivaNova PLC, Masimo, and Orthopediatrics Corp. NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. Nuvasive operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2900 people.

NuVasive Key Financial Ratios

NuVasive Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining NuVasive's current stock value. Our valuation model uses many indicators to compare NuVasive value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NuVasive competition to find correlations between indicators driving NuVasive's intrinsic value. More Info.NuVasive is regarded fifth in return on equity category among its peers. It also is regarded fifth in return on asset category among its peers reporting about  0.73  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for NuVasive is roughly  1.37 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NuVasive's earnings, one of the primary drivers of an investment's value.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

If you are still planning to invest in NuVasive check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NuVasive's history and understand the potential risks before investing.